Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prenatal Exposure Delayed Effects | 3 | 2012 | 155 | 1.140 |
Why?
|
| Smoking | 4 | 2015 | 775 | 0.920 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2012 | 60 | 0.840 |
Why?
|
| Maternal Exposure | 1 | 2012 | 40 | 0.450 |
Why?
|
| Paternal Behavior | 1 | 2011 | 8 | 0.430 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2011 | 18 | 0.420 |
Why?
|
| Data Interpretation, Statistical | 2 | 2016 | 188 | 0.420 |
Why?
|
| Self Report | 2 | 2015 | 315 | 0.420 |
Why?
|
| Maternal Behavior | 1 | 2011 | 32 | 0.410 |
Why?
|
| Pregnancy Outcome | 1 | 2010 | 176 | 0.370 |
Why?
|
| Cluster Analysis | 3 | 2016 | 239 | 0.350 |
Why?
|
| Pregnancy Complications | 1 | 2012 | 376 | 0.320 |
Why?
|
| Substance Abuse Detection | 2 | 2016 | 32 | 0.300 |
Why?
|
| Cohort Studies | 3 | 2012 | 2064 | 0.220 |
Why?
|
| Pregnancy | 3 | 2012 | 2055 | 0.200 |
Why?
|
| Birth Weight | 2 | 2010 | 78 | 0.190 |
Why?
|
| Monitoring, Ambulatory | 2 | 2016 | 57 | 0.180 |
Why?
|
| Wearable Electronic Devices | 1 | 2016 | 39 | 0.150 |
Why?
|
| Fuzzy Logic | 2 | 2016 | 4 | 0.150 |
Why?
|
| Secondary Prevention | 1 | 2016 | 123 | 0.150 |
Why?
|
| Cocaine-Related Disorders | 1 | 2015 | 64 | 0.140 |
Why?
|
| Asian Americans | 1 | 2015 | 50 | 0.140 |
Why?
|
| Drug Overdose | 1 | 2016 | 86 | 0.140 |
Why?
|
| Biosensing Techniques | 1 | 2016 | 107 | 0.140 |
Why?
|
| Young Adult | 3 | 2013 | 3650 | 0.130 |
Why?
|
| Merozoite Surface Protein 1 | 1 | 2013 | 18 | 0.120 |
Why?
|
| Attitude to Health | 1 | 2015 | 287 | 0.120 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1038 | 0.120 |
Why?
|
| Telemedicine | 1 | 2016 | 218 | 0.120 |
Why?
|
| Female | 8 | 2016 | 26315 | 0.110 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 334 | 0.110 |
Why?
|
| Malaria, Falciparum | 1 | 2013 | 100 | 0.110 |
Why?
|
| Plasmodium falciparum | 1 | 2013 | 122 | 0.110 |
Why?
|
| Opioid-Related Disorders | 1 | 2016 | 281 | 0.110 |
Why?
|
| Adult | 5 | 2016 | 13230 | 0.110 |
Why?
|
| Infant Behavior | 1 | 2010 | 3 | 0.110 |
Why?
|
| Boston | 1 | 2012 | 278 | 0.100 |
Why?
|
| Social Class | 1 | 2011 | 107 | 0.100 |
Why?
|
| Bias | 1 | 2010 | 102 | 0.100 |
Why?
|
| Smoking Cessation | 1 | 2015 | 569 | 0.100 |
Why?
|
| Infant, Newborn | 2 | 2010 | 1140 | 0.100 |
Why?
|
| Achievement | 1 | 2009 | 21 | 0.100 |
Why?
|
| Models, Psychological | 1 | 2009 | 97 | 0.090 |
Why?
|
| Child Development | 1 | 2009 | 72 | 0.090 |
Why?
|
| Humans | 9 | 2016 | 49403 | 0.090 |
Why?
|
| Developmental Disabilities | 1 | 2009 | 100 | 0.090 |
Why?
|
| Child | 3 | 2013 | 3728 | 0.090 |
Why?
|
| Skin Temperature | 2 | 2016 | 12 | 0.080 |
Why?
|
| Adolescent | 3 | 2013 | 5334 | 0.080 |
Why?
|
| Galvanic Skin Response | 2 | 2016 | 21 | 0.080 |
Why?
|
| Male | 6 | 2016 | 23184 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 2247 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2010 | 2532 | 0.060 |
Why?
|
| Wrist | 1 | 2016 | 27 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2016 | 49 | 0.040 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2016 | 52 | 0.040 |
Why?
|
| Republic of Korea | 1 | 2015 | 21 | 0.040 |
Why?
|
| Locomotion | 1 | 2016 | 100 | 0.040 |
Why?
|
| Motion | 1 | 2015 | 50 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 299 | 0.040 |
Why?
|
| Cocaine | 1 | 2015 | 75 | 0.040 |
Why?
|
| Culture | 1 | 2015 | 73 | 0.040 |
Why?
|
| Middle Aged | 3 | 2015 | 13458 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 758 | 0.030 |
Why?
|
| Smoking Prevention | 1 | 2015 | 208 | 0.030 |
Why?
|
| Family | 1 | 2015 | 194 | 0.030 |
Why?
|
| Hemoglobin, Sickle | 1 | 2013 | 9 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2016 | 742 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 383 | 0.030 |
Why?
|
| Parasitemia | 1 | 2013 | 30 | 0.030 |
Why?
|
| Kenya | 1 | 2013 | 81 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2013 | 42 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2013 | 129 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2013 | 180 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 439 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 1323 | 0.030 |
Why?
|
| Genotype | 1 | 2013 | 592 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 417 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2013 | 541 | 0.030 |
Why?
|
| Algorithms | 1 | 2016 | 887 | 0.030 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2009 | 24 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 760 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 161 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 1364 | 0.020 |
Why?
|
| Risk | 1 | 2009 | 363 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 1691 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 283 | 0.020 |
Why?
|
| Age Factors | 1 | 2009 | 1413 | 0.020 |
Why?
|
| United States | 1 | 2015 | 6206 | 0.020 |
Why?
|
| Aged | 1 | 2013 | 10866 | 0.010 |
Why?
|